Change of Adviser

One Health Group PLC

30 September 2024

 

30 September 2024

One Health Group PLC

("One Health" or "the 'Group")

Change of Adviser

One Health (AQSE: OHGR), an independent provider of free, high quality NHS care for patients referred through 'Patient Choice' for treatment in Orthopaedics, Spine, General Surgery and Gynaecology, is pleased to announce the appointment of Panmure Liberum Limited as the Company's AQSE Corporate Adviser and Broker with immediate effect.

For more information contact:

One Health Group PLC	Via Square1 Consulting
Derek Bickerstaff, Chairman
Adam Binns, CEO
Panmure Liberum Emma Earl, Will Goode, Mark Rogers, Joshua Borlant, Rupert Dearden	Tel: [phone]
Square1 Consulting
David Bick	Tel: [phone]          [phone]

Notes to Editors:

One Health engages over 100 NHS Consultants who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and in the year to March 2024 provided much needed care to 13,266 new patients, through almost 34,000 consultations and over 6,000 surgical procedures. One Health deploys surgeons and anaesthetists that are mostly employed by the NHS, on a subcontracted basis. It currently works with over 100 professionals across 8 independent hospitals and 35 CQC registered outreach clinics. Within these community-based outreach clinics all consultations and post operative physiotherapy is delivered where required, reducing patient inconvenience and excess travel.

One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. One Health has also sought to expand geographically from its Head Office in Sheffield into neighbouring counties, which meet these criteria. Currently, the Company's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue of over £23m in the year to 31 March 2024 was derived from over 60 NHS commissioning bodies in addition to contracts with local NHS Hospital Trusts to transfer their internal waiting list patients to One Health for quicker treatment.

One Health's business model has focused to date on four main areas: being Orthopaedics, Spine, General Surgery and Gynaecology. The split of inpatient procedures in the year to 31 March 2024 was as follows: Orthopaedics 46% Spine 22% General Surgery 22% Gynaecology 10%.

Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.

One Health delivered 6,169 procedures in the year to 31 March 2024 and the Directors expect the Company to deliver significantly more procedures in the year to 31 March 2025.

One Health was admitted to trading on Aquis in November 2022 with the ticker OHGR.AQ.

For additional information please visit https://www.aquis.eu/companies/OHGR

 

END